BOSTON, Dec 13 (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.



Latest News

ABC: Mom of girl, 16, who may have fled with older man pleads: 'Can you come home?'

Jpost: IDF shelling Hamas post near Gaza, Palestinian media reports

Daily Mail: Championship Results

Daily Mail: Championship Summaries

Daily Mail: After Ravens release, Woodhead announces retirement

FOX: Trump calls fired McCabe ‘choirboy’, suggests FBI corruption ‘at the highest levels’

FOX: Trump calls fired McCabe ‘choirboy’, suggests FBI corruption ‘at the highest levels’

Daily Mail: Video: Mercedes-Benz E-Class TV commercial ¿ ¿How does it feel?¿

Daily Mail: Video: Former Home and Away actor JAILED for sexually assaulting woman

Daily Mail: Jessie Wallace admits nerves filming first scenes back...

Daily Mail: Tottenham beats Swansea, secures 'home' FA Cup SF at...

Daily Mail: New FIFA 18 MOTM cards have upgrades for Messi, Higuain, and more

USA Today: Tottenham beats Swansea, secures 'home' FA Cup SF at Wembley

Jpost: An interview with global counterterrorism expert Fiamma Nirenstein

Ynet: Palestinian report: IDF fired tank shells on Gaza border

Daily Mail: Mauritius president resigns over credit card scandal

Daily Mail: China says resolutely opposed to new U.S. law on ties...

Daily Mail: Pop icon Kylie Minogue looks chic in Barcelona

Daily Mail: School board will debate settlement in teachers-cult...

BBC: Wrexham: Managerial vacancy sparks interest - club director

Daily Mail: Italy 27-29 Scotland: Greig Laidlaw saves Scotland

Daily Mail: Fiji mother killed own baby and avoids deportation from Australia

NewYorkTimes: On Tennis: Daria Kasatkina and Naomi Osaka Represent a New Wave